China Approves World's First Commercial Brain Chip

Summary

China has become the first nation to approve a brain chip for commercial use, a coin-sized implant designed by Shanghai-based Neuro Medical Technology to aid individuals with spinal cord injuries. This revolutionary brain-computer interface reads brain impulses and translates them into signals that can control external devices, such as robotic limbs, allowing users to perform tasks like grasping objects by simply thinking about it. This advancement is a significant step beyond Elon Musk's Neuralink, which is still in clinical trials. The Chinese government has declared brain-computer interfaces a national strategic priority, outlining a roadmap to lead the industry globally by 2030 and investing $1.7 billion to foster innovation. Beyond mobility assistance, a company called NeuroXS is developing technology to translate thoughts into real-time speech, offering a lifeline for those with speech impediments. This rapid commercialization in China, facilitated by faster regulatory approval processes compared to the US, highlights the nation's proactive approach to cutting-edge biotechnology.